ABMC

American Bio Medica Corporation

Set alert

Price alert · ABMC

All alert types
0.00 0.00 0.00%
As of Jul 2, 2025
0.0001 Day range 0.0001

52-week range unavailable

Open
0.0001
Prev close
0.0001
Mkt cap
4.81K
Vol
2.40K
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
0.0001
High
0.0001

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ABMC has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-44.22 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.2×
FY 2013: -3.7×FY 2014: -6.2×FY 2015: -10.1×FY 2016: -8.3×FY 2017: -5.3×FY 2018: -2.0×FY 2019: -3.3×FY 2020: -5.8×FY 2021: -3.5×FY 2022: -0.2×
FY 2013 5y median -3.3× FY 2022
P/S 0.3×
FY 2013: 0.3×FY 2014: 0.4×FY 2015: 0.5×FY 2016: 0.5×FY 2017: 0.6×FY 2018: 0.5×FY 2019: 0.6×FY 2020: 1.1×FY 2021: 0.7×FY 2022: 0.3×
FY 2013 5y median 0.6× FY 2022
P/B -0.1×
FY 2013: 2.2×FY 2014: 3.1×FY 2015: 3.5×FY 2016: 2.8×FY 2017: 4.7×FY 2018: -14.2×FY 2019: -2.9×FY 2020: -3.7×FY 2021: -1.7×FY 2022: -0.1×
FY 2013 5y median -2.9× FY 2022
P/FCF -0.3×
FY 2013: -116×FY 2014: 132×FY 2015: 16.1×FY 2016: 13.7×FY 2017: 25.0×FY 2018: -8.6×FY 2019: 39.3×FY 2020: -9.5×FY 2021: -2.4×FY 2022: -0.3×
FY 2013 5y median -2.4× FY 2022
EV/EBITDA -2.1×
FY 2013: -12.4×FY 2014: -36.5×FY 2015: 27.8×FY 2016: 123×FY 2017: -21.7×FY 2018: -5.3×FY 2019: -11.3×FY 2020: -11.9×FY 2021: -15.4×FY 2022: -2.1×
FY 2013 5y median -11.3× FY 2022
EV/Sales 2.7×
FY 2013: 0.5×FY 2014: 0.7×FY 2015: 0.8×FY 2016: 0.7×FY 2017: 0.9×FY 2018: 0.9×FY 2019: 1.1×FY 2020: 1.5×FY 2021: 1.4×FY 2022: 2.7×
FY 2013 5y median 1.4× FY 2022
FCF Yield -290.8%
FY 2013: -0.9%FY 2014: 0.8%FY 2015: 6.2%FY 2016: 7.3%FY 2017: 4.0%FY 2018: -11.7%FY 2019: 2.5%FY 2020: -10.5%FY 2021: -42.0%FY 2022: -290.8%
FY 2013 5y median -11.7% FY 2022

Profitability

Gross Margin -21.1%
FY 2013: 40.2%FY 2014: 42.0%FY 2015: 45.2%FY 2016: 44.4%FY 2017: 40.6%FY 2018: 33.3%FY 2019: 32.4%FY 2020: 29.9%FY 2021: 24.7%FY 2022: -21.1%
FY 2013 5y median 29.9% FY 2022
Operating Margin -136.0%
FY 2013: -12.7%FY 2014: -3.0%FY 2015: -3.6%FY 2016: -4.6%FY 2017: -6.3%FY 2018: -19.7%FY 2019: -16.2%FY 2020: -15.0%FY 2021: -53.2%FY 2022: -136.0%
FY 2013 5y median -19.7% FY 2022
Net Margin -154.4%
FY 2013: -8.9%FY 2014: -6.7%FY 2015: -5.3%FY 2016: -6.2%FY 2017: -11.1%FY 2018: -26.5%FY 2019: -18.6%FY 2020: -19.2%FY 2021: -20.9%FY 2022: -154.4%
FY 2013 5y median -20.9% FY 2022
ROE 60.3%
FY 2013: -58.9%FY 2014: -50.5%FY 2015: -34.7%FY 2016: -33.7%FY 2017: -87.5%FY 2018: 704.1%FY 2019: 86.2%FY 2020: 63.4%FY 2021: 49.0%FY 2022: 60.3%
FY 2013 5y median 63.4% FY 2022
ROIC 1254.5%
FY 2013: -29.6%FY 2014: -6.8%FY 2015: -7.7%FY 2016: -10.3%FY 2017: -16.0%FY 2018: -54.9%FY 2019: -72.1%FY 2020: -99.8%FY 2021: -175.4%FY 2022: 1254.5%
FY 2013 5y median -72.1% FY 2022
ROA -111.1%
FY 2013: -15.9%FY 2014: -12.0%FY 2015: -8.8%FY 2016: -10.2%FY 2017: -18.9%FY 2018: -41.5%FY 2019: -32.8%FY 2020: -41.3%FY 2021: -24.6%FY 2022: -111.1%
FY 2013 5y median -41.3% FY 2022

Growth (YoY)

Revenue -58.8%
FY 2013: -4.8%FY 2014: -18.1%FY 2015: -13.3%FY 2016: -11.2%FY 2017: -12.4%FY 2018: -21.2%FY 2019: -5.6%FY 2020: 13.5%FY 2021: -46.5%FY 2022: -58.8%
FY 2013 FY 2022
Operating Income -5.3%
FY 2013: -21.7%FY 2014: 80.8%FY 2015: -4.1%FY 2016: -13.7%FY 2017: -21.0%FY 2018: -145.0%FY 2019: 22.2%FY 2020: -4.7%FY 2021: -89.9%FY 2022: -5.3%
FY 2013 FY 2022
EPS (diluted) -172.2%
FY 2013: 30.5%FY 2014: 40.7%FY 2015: 38.1%FY 2016: 3.1%FY 2017: -48.4%FY 2018: -82.4%FY 2019: 38.7%FY 2020: -7.2%FY 2021: 51.8%FY 2022: -172.2%
FY 2013 FY 2022
Free Cash Flow -14.1%
FY 2013: -112.4%FY 2014: 192.0%FY 2015: 808.7%FY 2016: 1.0%FY 2017: -44.5%FY 2018: -306.8%FY 2019: 124.0%FY 2020: -939.7%FY 2021: -38.2%FY 2022: -14.1%
FY 2013 FY 2022

Financial Health

Current Ratio 0.2×
FY 2013: 1.1×FY 2014: 1.1×FY 2015: 1.5×FY 2016: 1.5×FY 2017: 1.3×FY 2018: 0.9×FY 2019: 0.7×FY 2020: 0.6×FY 2021: 0.5×FY 2022: 0.2×
FY 2013 5y median 0.6× FY 2022
Quick Ratio 0.1×
FY 2013: 0.5×FY 2014: 0.5×FY 2015: 0.5×FY 2016: 0.5×FY 2017: 0.3×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.3×FY 2021: 0.3×FY 2022: 0.1×
FY 2013 5y median 0.3× FY 2022
Debt / Equity -1.0×
FY 2013: 1.7×FY 2014: 2.2×FY 2015: 1.9×FY 2016: 1.4×FY 2017: 2.1×FY 2018: -10.5×FY 2019: -2.0×FY 2020: -1.5×FY 2021: -1.7×FY 2022: -1.0×
FY 2013 5y median -1.7× FY 2022
Net Debt / EBITDA -1.9×
FY 2013: -4.4×FY 2014: -13.7×FY 2015: 9.1×FY 2016: 38.6×FY 2017: -6.6×FY 2018: -2.1×FY 2019: -4.6×FY 2020: -3.3×FY 2021: -7.4×FY 2022: -1.9×
FY 2013 5y median -3.3× FY 2022
Interest Coverage -6.4×
FY 2013: -3.6×FY 2014: -0.9×FY 2015: -0.5×FY 2016: -0.9×FY 2017: -1.1×FY 2018: -2.7×FY 2019: -2.2×FY 2020: -3.5×FY 2021: -6.1×FY 2022: -6.4×
FY 2013 5y median -3.5× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31